| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.89▼ | 1.93▼ | 1.93▼ | 2.06▼ | 1.62▲ |
| MA10 | 2.04▼ | 2.06▼ | 2.06▼ | 1.86▼ | 1.50▲ |
| MA20 | 2.09▼ | 2.13▼ | 2.10▼ | 1.64▲ | 1.60▲ |
| MA50 | 2.10▼ | 1.77▲ | 1.73▲ | 1.50▲ | 1.81▲ |
| MA100 | 1.81▲ | 1.59▲ | 1.57▲ | 1.61▲ | 1.92▼ |
| MA200 | 1.64▲ | 1.65▲ | 1.65▲ | 1.80▲ | 2.33▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.045▼ | -0.064▼ | -0.060▼ | 0.045▲ | 0.052▲ |
| RSI | 35.958▼ | 44.100▼ | 46.348▼ | 54.089▲ | 54.297▲ |
| STOCH | 0.000▼ | 9.115▼ | 9.115▼ | 56.158 | 51.067 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -60.766 | -54.480 |
| CCI | -108.382▼ | -122.593▼ | -122.593▼ | 22.064 | 163.568▲ |
|
Thursday, May 21, 2026 09:03 PM
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“ Innate ” or the “ Company ”) announced the voting results of its shareholders at the Annual General Meeting (“AGM”), which took place on May 21, ...
|
|
Monday, May 18, 2026 10:00 PM
Innate Pharma S.A. is a global, clinical-stage biotechnology company developing immunotherapies for cancer patients. Leveraging its expertise on antibody-engineering and innovative target ...
|
|
Thursday, May 14, 2026 05:17 AM
Operator: Ladies and gentlemen, thank you for joining, and welcome to the Innate Pharma First Quarter 2026 Business Update and Financial Results.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/05/26 | 1.91 | 1.94 | 1.82 | 1.83 | 14,301 |
| 21/05/26 | 2.18 | 2.18 | 1.97 | 1.97 | 48,698 |
| 20/05/26 | 2.08 | 2.2971 | 2.08 | 2.20 | 29,488 |
| 19/05/26 | 2.20 | 2.28 | 1.99 | 2.03 | 78,559 |
| 18/05/26 | 2.18 | 2.315 | 2.17 | 2.25 | 114,350 |
| 15/05/26 | 2.16 | 2.16 | 1.9316 | 2.02 | 209,348 |
| 14/05/26 | 1.70 | 2.6199 | 1.5601 | 2.17 | 2,370,470 |
| 13/05/26 | 1.41 | 1.41 | 1.32 | 1.32 | 9,256 |
| 12/05/26 | 1.40 | 1.40 | 1.3367 | 1.36 | 2,970 |
| 11/05/26 | 1.42 | 1.48 | 1.42 | 1.42 | 5,219 |
|
|
||||
|
|
||||
|
|